John D. Klement

1.8k total citations
33 papers, 1.3k citations indexed

About

John D. Klement is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, John D. Klement has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 21 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in John D. Klement's work include Cancer Immunotherapy and Biomarkers (18 papers), Immune cells in cancer (12 papers) and Immune Cell Function and Interaction (11 papers). John D. Klement is often cited by papers focused on Cancer Immunotherapy and Biomarkers (18 papers), Immune cells in cancer (12 papers) and Immune Cell Function and Interaction (11 papers). John D. Klement collaborates with scholars based in United States, Georgia and China. John D. Klement's co-authors include Kebin Liu, Chunwan Lu, Priscilla S. Redd, Dafeng Yang, Mohammed L. Ibrahim, Dakota B. Poschel, Wei Xiao, Amy V. Paschall, Asha Nayak-Kapoor and Esteban Celis and has published in prestigious journals such as Science, Journal of Clinical Investigation and ACS Nano.

In The Last Decade

John D. Klement

33 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John D. Klement United States 19 610 550 519 270 223 33 1.3k
Priscilla S. Redd United States 15 617 1.0× 553 1.0× 444 0.9× 209 0.8× 189 0.8× 27 1.2k
Nikita Kolhatkar United States 13 1.2k 2.0× 682 1.2× 433 0.8× 219 0.8× 113 0.5× 18 1.8k
Yael Raz Israel 12 451 0.7× 682 1.2× 614 1.2× 263 1.0× 126 0.6× 17 1.2k
Sajida Piperdi United States 17 252 0.4× 521 0.9× 410 0.8× 222 0.8× 464 2.1× 25 1.1k
Michele Minopoli Italy 17 625 1.0× 478 0.9× 479 0.9× 261 1.0× 163 0.7× 22 1.3k
Miranda Buitenhuis Netherlands 19 378 0.6× 431 0.8× 506 1.0× 143 0.5× 91 0.4× 30 1.3k
Carmen Oñate Spain 12 1.1k 1.7× 1.0k 1.8× 354 0.7× 139 0.5× 197 0.9× 19 1.7k
Zhenke Wen China 25 1.1k 1.8× 272 0.5× 718 1.4× 415 1.5× 279 1.3× 62 1.9k
Takumi Maruhashi Japan 15 986 1.6× 1.1k 1.9× 363 0.7× 92 0.3× 142 0.6× 23 1.7k

Countries citing papers authored by John D. Klement

Since Specialization
Citations

This map shows the geographic impact of John D. Klement's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John D. Klement with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John D. Klement more than expected).

Fields of papers citing papers by John D. Klement

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John D. Klement. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John D. Klement. The network helps show where John D. Klement may publish in the future.

Co-authorship network of co-authors of John D. Klement

This figure shows the co-authorship network connecting the top 25 collaborators of John D. Klement. A scholar is included among the top collaborators of John D. Klement based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John D. Klement. John D. Klement is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Redd, Priscilla S., et al.. (2024). In vitro antibody-mediated SARS-CoV-2 infection suppression through human ACE2 receptor blockade. Immunology Letters. 268. 106887–106887. 1 indexed citations
2.
Poschel, Dakota B., John D. Klement, Chunwan Lu, et al.. (2024). PD-L1 restrains PD-1+Nrp1lo Treg cells to suppress inflammation-driven colorectal tumorigenesis. Cell Reports. 43(10). 114819–114819. 4 indexed citations
3.
Klement, John D., Priscilla S. Redd, Chunwan Lu, et al.. (2023). Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment. Cancer Cell. 41(3). 620–636.e9. 83 indexed citations
4.
Poschel, Dakota B., John D. Klement, Dafeng Yang, et al.. (2023). IRF8 Regulates Intrinsic Ferroptosis through Repressing p53 Expression to Maintain Tumor Cell Sensitivity to Cytotoxic T Lymphocytes. Cells. 12(2). 310–310. 5 indexed citations
5.
Zheng, Linghua, Xue Han, Sheng Yao, et al.. (2022). The CD8α–PILRα interaction maintains CD8 + T cell quiescence. Science. 376(6596). 996–1001. 15 indexed citations
6.
Poschel, Dakota B., Priscilla S. Redd, John D. Klement, et al.. (2022). Lipid Nanoparticle Delivery of Fas Plasmid Restores Fas Expression to Suppress Melanoma Growth In Vivo. ACS Nano. 16(8). 12695–12710. 30 indexed citations
7.
Lu, Chunwan, Dafeng Yang, John D. Klement, et al.. (2022). H3K9me3 represses G6PD expression to suppress the pentose phosphate pathway and ROS production to promote human mesothelioma growth. Oncogene. 41(18). 2651–2662. 19 indexed citations
8.
Zhu, Huabin, John D. Klement, Chunwan Lu, et al.. (2021). Asah2 Represses the p53–Hmox1 Axis to Protect Myeloid-Derived Suppressor Cells from Ferroptosis. The Journal of Immunology. 206(6). 1395–1404. 96 indexed citations
9.
Klement, John D., et al.. (2021). Expression regulation and function of PD-1 and PD-L1 in T lymphoma cells. Cellular Immunology. 366. 104397–104397. 7 indexed citations
10.
Lu, Chunwan, Amy V. Paschall, John D. Klement, et al.. (2020). Autocrine IL6-Mediated Activation of the STAT3–DNMT Axis Silences the TNFα–RIP1 Necroptosis Pathway to Sustain Survival and Accumulation of Myeloid-Derived Suppressor Cells. Cancer Research. 80(15). 3145–3156. 61 indexed citations
11.
Lu, Chunwan, John D. Klement, Dafeng Yang, et al.. (2020). SUV39H1 regulates human colon carcinoma apoptosis and cell cycle to promote tumor growth. Cancer Letters. 476. 87–96. 30 indexed citations
12.
Ibrahim, Mohammed L., Chunwan Lu, John D. Klement, et al.. (2020). Expression profiles and function of IL6 in polymorphonuclear myeloid-derived suppressor cells. Cancer Immunology Immunotherapy. 69(11). 2233–2245. 13 indexed citations
13.
Lu, Chunwan, et al.. (2020). MS4A1 expression and function in T cells in the colorectal cancer tumor microenvironment. Cellular Immunology. 360. 104260–104260. 36 indexed citations
14.
Poschel, Dakota B., et al.. (2020). Osteopontin: A Key Regulator of Tumor Progression and Immunomodulation. Cancers. 12(11). 3379–3379. 99 indexed citations
15.
Lu, Chunwan, John D. Klement, Mohammed L. Ibrahim, et al.. (2019). Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytes. Journal for ImmunoTherapy of Cancer. 7(1). 157–157. 96 indexed citations
16.
Klement, John D., Amy V. Paschall, Priscilla S. Redd, et al.. (2019). Repression of osteopontin by IRF8 regulates a novel immunosuppressive checkpoint. The Journal of Immunology. 202(1_Supplement). 195.26–195.26. 1 indexed citations
17.
Xiao, Wei, Mohammed L. Ibrahim, Priscilla S. Redd, et al.. (2018). Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor Immunotherapy. Molecular Cancer Research. 17(2). 420–430. 37 indexed citations
18.
Ibrahim, Mohammed L., John D. Klement, Chunwan Lu, et al.. (2018). Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis. Cell Reports. 25(11). 3036–3046.e6. 76 indexed citations
19.
Klement, John D., Amy V. Paschall, Priscilla S. Redd, et al.. (2018). An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasion. Journal of Clinical Investigation. 128(12). 5549–5560. 235 indexed citations
20.
Redd, Priscilla S., Mohammed L. Ibrahim, John D. Klement, et al.. (2017). SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor Cells. Cancer Research. 77(11). 2834–2843. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Priscilla S. Redd Breakdown of academic impact, for papers by Nikita Kolhatkar Breakdown of academic impact, for papers by Yael Raz Breakdown of academic impact, for papers by Sajida Piperdi Breakdown of academic impact, for papers by Michele Minopoli Breakdown of academic impact, for papers by Miranda Buitenhuis Breakdown of academic impact, for papers by Carmen Oñate Breakdown of academic impact, for papers by Zhenke Wen Breakdown of academic impact, for papers by Takumi Maruhashi
Rankless by CCL
2026